Daridorexant

FDA Drug Profile — QUVIVIQ

Daridorexant is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including QUVIVIQ. Available dosage forms: tablet, film coated, powder.

Drug details

Generic Name
Daridorexant
Brand Names
QUVIVIQ
Application Number
NDA214985
Sponsor
Idorsia Pharmaceuticals Ltd
NDC Codes
3
Dosage Forms
TABLET, FILM COATED, POWDER
Routes
ORAL
Active Ingredients
DARIDOREXANT

Indications and Usage

1 INDICATIONS AND USAGE QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies (14.1) ] . QUVIVIQ is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.